Thermaquil, Inc.
Wayne, PA
- UEI
- S8FTDLJNX2K5
- CAGE
- 81HF2
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 230 Sugartown Rd #100, Wayne, PA 19087, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase II: drug free noninvasive occipital nerve block device to reduce opiate prescriptions | National Science Foundation | $1,199,999 | |
| Drug free nerve block device for the relief of pain and symptoms in migraines and other headaches - abstract:… | National Institute of Neurological Disorders and Stroke | $4,349,462 | |
| Customer discovery for minimally invasive nerve block device to treat severe pain and reduce usage of opiates | National Institute of Neurological Disorders and Stroke | $554,325 | |
| Sttr phase i: minimally-invasive reversible thermal nerve block for relief of severe pain | Division of Industrial Innovation | $225,000 |
About Thermaquil, Inc.
Thermaquil, Inc. is a corporate entity providing medical devices and services to the federal government. As a self-certified small business, Thermaquil develops nerve block technology to treat pain associated with migraines, headaches, and other neurological conditions.
Through a subcontract with the University of Pittsburgh, Thermaquil serves as project integrator on a spinal cord injury research program sponsored by the federal government. In this capacity, Thermaquil coordinates overall project management, represents customer needs, leads FDA communications, oversees preclinical studies, and will sponsor human clinical trials aimed at restoring bladder, bowel, and sexual function in people with spinal cord injuries.
Thermaquil has received four prime federal grants from the National Institutes of Health and National Science Foundation supporting development of its nerve block medical device technology. These include Small Business Innovation Research (SBIR) grants and cooperative agreements funding further research, testing, and commercialization of a noninvasive nerve block device to treat migraines, reduce opioid use for pain management, and provide an alternative to drug therapies. Grant awards have also supported Thermaquil’s early customer discovery efforts related to commercialization of its minimally invasive pain management device.
Quick answers
What is Thermaquil, Inc.'s UEI?
Thermaquil, Inc.'s Unique Entity ID (UEI) in SAM.gov is S8FTDLJNX2K5.
What is Thermaquil, Inc.'s CAGE code?
Thermaquil, Inc.'s CAGE code is 81HF2.
What is Thermaquil, Inc.'s primary NAICS code?
Thermaquil, Inc.'s primary NAICS code is 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing).
Where is Thermaquil, Inc. located?
Thermaquil, Inc.'s physical address in SAM.gov is 230 Sugartown Rd #100, Wayne, PA 19087, USA.
Is Thermaquil, Inc. registered in SAM.gov?
Thermaquil, Inc.'s SAM.gov registration expired on September 16, 2026.
What is Thermaquil, Inc.'s most recent federal award?
Thermaquil, Inc.'s most recent federal grant award is Sbir phase II: drug free noninvasive occipital nerve block device to reduce opiate prescriptions (2026112), from National Science Foundation, on September 15, 2020.
On GovTribe
See Thermaquil, Inc.'s full federal record
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors